作　　者： (冯宗英）;

机构地区： 四川省达州市中西医结合医院CT室,四川达州635000

出　　处： 《吉林医学》 2017年第9期1662-1665,共4页

摘　　要： 目的:评价CT联合MRI诊断早期中央型肺癌及术后复发的临床价值。方法:选取医院诊断怀疑为早期中央型肺癌患者114例,均进行MRI、CT检查、实验室检查,以手术病理作为最终诊断。术后常规定期检测肿瘤标志物水平,对怀疑为复发或转移者,进行MRI、CT检查。结果:CT联合MRI定位诊断符合率100.00%,手术病理与CT联合MRI诊断高度一致;45例肺癌患者,均采用根治手术治疗,随访6个月~3年,CT联合MRI诊断复发敏感性100.00%(24/24),特异度70.97%(22/31),假阳性主要为慢性炎症、纵隔淋巴结肿大。结论:CT联合MRI诊断早期中央型肺癌的效果较好,可指导手术治疗,作为术后复发的诊断策略,但需与慢性炎症、纵隔淋巴结肿大相鉴别。 Objective To evaluate the clinical value of CT combined with MRI in the diagnosis of early central lung cancer and postoperative recurrence. Method 114 patients with suspected early central lung cancer were examined by MRI,CT and laboratory examination. The level of tumor markers was detected regularly after operation. MRI and CT were performed in patients with suspected recurrence or metastasis. Results The rate of 100. 00% according to the diagnostic localization of CT combined with MRI,CT and MRI combined with pathological diagnosis highly consistent; 45 cases of lung cancer patients were given radical surgery,followed up for 6 months to 3 years,CT combined with MRI in the diagnosis of recurrent sensitivity 100. 00%（ 24/24）,the specificity of 70. 97%（ 22/31）,false positive for chronic inflammation,longitudinal mediastinal lymph node enlargement. Conclusion CT combined with MRI in the diagnosis of early central lung cancer has a better effect,and can guide the surgical treatment,as a diagnostic strategy for postoperative recurrence,but it needs to be differentiated from chronic inflammation and mediastinal lymph node enlargement.

关 键 词： 中央型肺癌 术后复发